An intrinsic timer that controls cell-cycle withdrawal in cultured cardiac myocytes

Developmental Biology

Volumn 216, Issue 2, 1999, Pages 659-670

  Burton, P B J ^a   Raff, M C ^b   Kerr, P ^c   Yacoub, M H ^a   Barton, P J R ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Cell cycle; Culture; Differentiation; Heart; Timer

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; PROTEIN P27; THYROID HORMONE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL CYCLE; CELL DIFFERENTIATION; CELL DIVISION; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; EMBRYO; FEMALE; FETUS; HEART MUSCLE CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TIME;

ANIMALIA;

EID: 0033572547     PISSN: 00121606     EISSN: None     Source Type: Journal    
DOI: 10.1006/dbio.1999.9524     Document Type: Article

References (49)

1. Ahlgren S. C., Wallace H., Bishop J., Neophytou C., Raff M. C. Effects of thyroid hormone on embryonic oligodendrocyte precursor cell development in vivo and in vitro. Mol. Cell Neurosci. 9:1997;420-432.
2. Baas D., Bourbeau D., Sarlieve L. L., Ittel M. E., Dussault J. H., Puymirat J. Oligodendrocyte maturation and progenitor cell proliferation are independently regulated by thyroid hormone. Glia. 19:1997;324-332.
3. Barres B. A., Lazar M. A., Raff M. C. A novel role for thyroid hormone, glucocorticoids and retinoic acid in timing oligodendrocyte development. Development. 120:1994;1097-1108.
4. Barres B. A., Raff M. C. Control of oligodendrocyte number in the developing rat optic nerve. Neuron. 12:1994;935-942.
5. Bogler O., Noble M. Measurement of time in oligodendrocyte-type-2 astrocyte (O-2A) progenitors is a cellular process distinct from differentiation or division. Dev. Biol. 162:1994;525-538.
6. Burton P. B. J., Yacoub M. H., Barton P. J. R. Cyclin dependent kinase inhibitor expression in human heart failure: A comparison with development. Eur. Heart J. 20:1999;604-611.
7. Chien K. R., Knowlton K. U., Zhu H., Chien S. Regulation of cardiac gene expression during myocardial growth and hypertrophy: Molecular studies of an adaptive physiologic response. FASEB J. 5:1991;3037-3046.
8. Disatnik M. H., Jones S. N., Mochly R. D. Stimulus-dependent subcellular localization of activated protein kinase C: A study with acidic fibroblast growth factor and transforming growth factor-beta 1 in cardiac myocytes. J. Mol. Cell Cardiol. 27:1995;2473-2481.
9. Durand B., Gao F. B., Raff M. Accumulation of the cyclin-dependent kinase inhibitor p27/Kip1 and the timing of oligodendrocyte differentiation. EMBO J. 16:1997;306-317.
10. Enesco M., Leblond C. P. Increase in cell number as a factor in the growth of the organs and tissues of the young male rat. J. Embryol. Exp. Morphol. 10:1962;530-562.
11. Fantes P., Nurse P. Control of cell size at division in fission yeast by a growth-modulated size control over nuclear division. Exp. Cell Res. 107:1977;377-386.
12. Fero M. L., Rivkin M., Tasch M., Porter P., Carow C. E., Firpo E., Polyak K., Tsai L. H., Broudy V., Perlmutter R. M., Kaushansky K., Roberts J. M. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell. 85:1996;733-744.
13. Fishman M. C., Olson E. N. Parsing the heart: Genetic modules for organ assembly. Cell. 91:1997;153-156.
14. Franklin D. S., Godfrey V. L., Lee H., Kovalev G. I., Schoonhoven R., Chen K. S., Su L., Xiong Y. CDK inhibitors p18(INK4c) and p27(Kip1) mediate two separate pathways to collaboratively suppress pituitary tumorigenesis. Genes Dev. 12:1998;2899-2911.
15. Fukuda K., Izumo S. Angiotensin II potentiates DNA synthesis in AT-1 transformed cardiomyocytes. J. Mol. Cell Cardiol. 30:1998;2069-2080.
16. Gao F. B., Durand B., Raff M. Oligodendrocyte precursor cells count time but not cell divisions before differentiation. Curr. Biol. 7:1997;152-155.
17. Gao F. B., Raff M. C. Cell size control and a cell-intrinsic maturation program in proliferating oligodendrocyte precursor cells. J. Cell Biol. 138:1997;1367-1377.
18. Gustafson T. A., Bahl J. J., Markham B. E., Roeske W. R., Morkin E. Hormonal regulation of myosin heavy chain and alpha-actin gene expression in cultured fetal rat heart myocytes. J. Biol. Chem. 262:1987;13316-13322.
19. Ibarrola N., Mayer P. M., Rodriguez P. A., Noble M. Evidence for the existence of at least two timing mechanisms that contribute to oligodendrocyte generation in vitro. Dev. Biol. 180:1996;1-21.
20. Ikram Z., Norton T., Jat P. S. The biological clock that measures the mitotic life-span of mouse embryo fibroblasts continues to function in the presence of simian virus 40 large tumor antigen. Proc. Natl. Acad. Sci. USA. 91:1994;6448-6452.
21. Killander D., Zetterberg A. A quantitative cytochemical investigation of the relationship between cell mass and initiation of DNA synthesis in mouse fibroblasts in vitro. Exp. Cell Res. 40:1965;12-20.
22. Kiyokawa H., Kineman R. D., Manova T. K., Soares V. C., Hoffman E. S., Ono M., Khanam D., Hayday A. C., Frohman L. A., Koff A. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell. 85:1996;721-732.
23. Koh K. N., Kang M. J., Frith T. A., Park S. K., Kim I., Lee C. O., Koh G. Y. Persistent and heterogeneous expression of the cyclin-dependent kinase inhibitor, p27KIP1, in rat hearts during development. J. Mol. Cell Cardiol. 30:1998;463-474.
24. Li F., Wang X., Capasso J. M., Gerdes A. M. Rapid transition of cardiac myocytes from hyperplasia to hypertrophy during postnatal development. J. Mol. Cell Cardiol. 28:1996;1737-1746.
25. Nakayama K., Ishida N., Shirane M., Inomata A., Inoue T., Shishido N., Horii I., Loh D. Y. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell. 85:1996;707-720.
26. Noble M., Murray K. Purified astrocytes promote the in vitro division of a bipotential glial progenitor cell. EMBO J. 3:1984;2243-2247.
27. Noble M., Murray K., Stroobant P., Waterfield M. D., Riddle P. Platelet-derived growth factor promotes division and motility and inhibits premature differentiation of the oligodendrocyte/type-2 astrocyte progenitor cell. Nature. 333:1988;560-562.
28. Olson E. N., Srivastava D. Molecular pathways controlling heart development. Science. 272:1996;671-676.
29. Orend G., Hunter T., Ruoslahti E. Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells. Oncogene. 16:1998;2575-2583.
30. Poolman R. A., Brooks G. Expressions and activities of cell cycle regulatory molecules during the transition from myocyte hyperplasia to hypertrophy. J. Mol. Cell Cardiol. 30:1998;2121-2135.
31. Poolman R. A., Li J.-M., Durand B., Brooks G. Altered expression of cell cycle proteins and prolonged duration of cardiac myocyte hyperplasia in p27KIP1 knockout mice. Circ. Res. 85:1999;117-127.
32. Prescott D. M. Relation between cell growth and cell division. Exp. Cell Res. 11:1956;86-98.
33. Prescott D. M. Variations in the individual generation times of Tetrahymena geleii. Exp. Cell Res. 16:1959;279-284.
34. Quinn L. S., Holtzer H., Nameroff M. Generation of chick skeletal muscle cells in groups of 16 from stem cells. Nature. 313:1985;692-694.
35. Raff M. C., Abney E. R., Fok S. J. Reconstitution of a developmental clock in vitro: A critical role for astrocytes in the timing of oligodendrocyte differentiation. Cell. 42:1985;61-69.
36. Raff M. C., Durand B., Gao F. B. Cell number control and timing in animal development: The oligodendrocyte cell lineage. Int. J. Dev. Biol. 42:1998;263-267.
37. Raff M. C., Lillien L. E., Richardson W. D., Burne J. F., Noble M. D. Platelet-derived growth factor from astrocytes drives the clock that times oligodendrocyte development in culture. Nature. 333:1988;562-565.
38. Richardson W. D., Pringle N., Mosley M. J., Westermark B., Dubois D. M. A role for platelet-derived growth factor in normal gliogenesis in the central nervous system. Cell. 53:1988;309-319.
39. Robbins J. Regulation of cardiac gene expression during development. Card. Res. 31:1996;E2-E16.
40. Rumyantsev P. P. DNA synthesis and mitotic division of myocytes from ventricles, atria and conductive system of the heart during myocardial development in mammals. Tsitologiya. 20:1978;132-142.
41. Santalucia T., Camps M., Castello A., Munoz P., Nuel A., Testar X., Palacin M., Zorzano A. Developmental regulation of GLUT-1 (erythroid/HepG2) and GLUT-4 (muscle/fat) glucose transporter expression in rat heart, skeletal muscle and brown adipose tissue. Endocrinology. 130:1992;837-846.
42. Sasse S., Brand N. J., Kyprianou P., Dhoot G. K., Wade R., Arai M., Periasamy M., Yacoub M. H., Barton P. J. R. Troponin I gene expression during human cardiac development and in end-stage heart failure. Circ. Res. 72:1993;932-938.
43. Scheinowitz M., Kotlyar A., Zimand S., Ohad D., Leibovitz I., Bloom N., Goldberg I., Nass D., Engelberg S., Savion N., Eldar M. Basic fibroblast growth factor induces myocardial hypertrophy following acute infarction in rats. Exp. Physiol. 83:1998;585-593.
44. Temple S., Raff M. C. Differentiation of a bipotential glial progenitor cell in a single cell microculture. Nature. 313:1985;223-225.
45. Temple S., Raff M. C. Clonal analysis of oligodendrocyte development in culture: Evidence for a developmental clock that counts cell divisions. Cell. 44:1986;773-779.
46. Thomas G. V., Szigeti K., Murphy M., Draetta G., Pagano M., Loda M. Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastases. Am. J. Pathol. 153:1998;681-687.
47. Vozzi C., Dupont E., Coppen S. R., Severs N. Chamber-related differences in connexin expression in the human heart. J. Mol. Cell. Cardiol. 31:1999;991-1003.
48. Winick M., Noble A. Quantitative changes in DNA, RNA and protein during prenatal and postnatal growth in the rat. Dev. Biol. 12:1965;451-466.
49. Yaroslavskiy B., Watkins S., Donnenberg A. D., Patton T. J., Steinman R. A. Subcellular and cell-cycle expression profiles of CDK-inhibitors in normal differentiating myeloid cells. Blood. 93:1999;2907-2917.